Vertex names Jonathan Poole finance chief as Crinetics buy closes
Vertex Pharmaceuticals is appointing Jonathan Poole as CFO in connection with its $10 billion acquisition of Crinetics Pharmaceuticals. Poole is currently senior vice president of finance and will become executive vice president, finance.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.